However, Baranova et al. (2003) subsequently reported downregulated expression of TRIM13 in CLL patients at advanced stage of disease in comparison to expression at diagnosis, suggesting that it does exhibit properties of a tumour suppressor. The gene discussed is TRIM13; the disease is B-cell chronic lymphocytic leukemia.